are there any oral glp-1 drugs GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Lesson: Oral Semaglutide: A New
Description
Summary: Hair loss from GLP-1 medications is typically temporary telogen effluvium caused by rapid weight loss and nutritional changes, manageable through adequate protein intake, micronutrient optimisation, and moderating weight reduction rate
The magnets are then naturally expelled, leaving nothing behind
doi: 10.1111/jcmm.12689 [DOI] [PMC free article] [PubMed] [Google Scholar] 50.Nagashima M, Watanabe T, Terasaki M, et al
Cardiovasc Drugs Ther
[DOI] [PubMed] [Google Scholar] 42.Odah T., Vattikonda A., Stark M., Brahmbhatt B., Lukens F.J., Badurdeen D., Hashash J.G., Farraye F.A
In the LEAN trial, Liraglutide was shown to have a higher rates of NASH resolution and lower rates of fibrosis progression compared to placebo
